247 results on '"Schepens, Bert"'
Search Results
2. Yeast-based production platform for potent and stable heavy chain-only antibodies
3. Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies
4. A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults : A First-in-Humans Study
5. Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist
6. Clinical Potential of Prefusion RSV F-specific Antibodies
7. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
8. GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery
9. Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike
10. GM-CSF treatment prevents respiratory syncytial virus–induced pulmonary exacerbation responses in postallergic mice by stimulating alveolar macrophage maturation
11. Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice
12. Super-resolution microscopy reveals significant impact of M2e-specific monoclonal antibodies on influenza A virus filament formation at the host cell surface
13. Cutting Edge Approaches Toward Novel and Cross-Protective Influenza Vaccines
14. An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25
15. CD8+ T cell immunity against human respiratory syncytial virus
16. Correction: Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
17. Regulation of kynurenine biosynthesis during influenza virus infection
18. GlycoVHH: Introducing N-glycans on the camelid VHH antibody scaffold - Optimal sites and use for macrophage delivery
19. How RSV Proteins Join Forces to Overcome the Host Innate Immune Response
20. Nanobodies ® Specific for Respiratory Syncytial Virus Fusion Protein Protect Against Infection by Inhibition of Fusion
21. Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection
22. Nanobodies®: New ammunition to battle viruses
23. An affinity-enhanced, broadly neutralizing heavy chain–only antibody protects against SARS-CoV-2 infection in animal models
24. In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression
25. Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein
26. A Vulnerable, Membrane-Proximal Site in Human Respiratory Syncytial Virus F Revealed by a Prefusion-Specific Single-Domain Antibody
27. Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodents
28. Single-domain antibodies make a difference
29. Single Domain Camelid Antibodies that Neutralize Negative Strand Viruses
30. Hepatitis B core–based virus–like particles to present heterologous epitopes
31. A two-amino acid mutation in murine IgA enables downstream processing and purification on staphylococcal superantigen-like protein 7
32. Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein
33. mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice
34. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
35. STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters
36. Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection
37. The polypyrimidine tract-binding protein stimulates HIF-1α IRES-mediated translation during hypoxia
38. UNR translation can be driven by an IRES element that is negatively regulated by polypyrimidine tract binding protein
39. Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses
40. Vaccination with influenza hemagglutinin-loaded ceramic nanoporous microneedle arrays induces protective immune responses
41. Single-Domain Antibodies and Their Formatting to Combat Viral Infections
42. Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λ
43. Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice
44. Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization
45. Vaccine options for influenza: thinking small
46. Transiently Thermoresponsive Acetal Polymers for Safe and Effective Administration of Amphotericin B as a Vaccine Adjuvant
47. Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection
48. Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies
49. Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
50. IgG3 Snitcher of RSV Infections in the Very Young
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.